At what stage is this treatment used?
- Adjuvant treatment of stage III (Dukes C) colon cancer in combination with fluoropyrimidine agent.
- In combination with fluorouracil and folinic acid for the treatment of metastatic bowel cancer.
- In combination with capecitabine, with or without bevacizumab, for the treatment of patients with metastatic bowel cancer.
Is this drug available via the Pharmaceutical Benefits Scheme (PBS) as a subsidised treatment?
Download the Consumer Medicine Information (CMI) for Eloxatin.
